Joshua Tindall
Psychiatric/Mental Health · Miamisburg, OHNPI 1336868827
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,000 of the $9,946 with a category attached, or 60.3%. AbbVie accounts for 80.4% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $7,592, more than ten times the $702 reported in 2023. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $46.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$8K
- Otsuka America Pharmaceutical, Inc.$453
- Axsome Therapeutics, Inc.$328
- Teva Pharmaceuticals USA, Inc.$144
- Lundbeck LLC$134
- Almatica Pharma LLC$125
- plus $766 from 12 others
What the payments were for
- Speaking & faculty fees$6,00060%
- Travel & lodging$350%
- Food & beverage$3,91139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,946 in reported general payments places this provider in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 20 | $26,553 |
| RexultiBrexpiprazole | 17 | $24,313 |
| Lamotrigine ErLamotrigine | 20 | $2,302 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 20 | $1,546 |
| Lamotrigine | 124 | $1,170 |
| Quetiapine Fumarate | 58 | $584 |
| Naltrexone Hcl | 11 | $418 |
| Lithium Carbonate ErLithium Carbonate | 31 | $369 |
| Lorazepam | 49 | $233 |
| Lithium Carbonate | 29 | $231 |
| Clonazepam | 27 | $188 |
| Clonidine Hcl | 24 | $66 |
| Zolpidem Tartrate | 31 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $7,997 | $26,55320 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $453 | $24,31317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Miamisburg
- Emilie BreedingMiamisburg$40K
- Ashley GouldMiamisburg$10K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.